ESMO 2023 BioNTech Data slide image

ESMO 2023 BioNTech Data

_2 BNT325/DB-1305 DB-1305 (a Trop-2 targeted antibody-drug-conjugate [ADC]) in patients with advanced solid tumors: Preliminary clinical results from the Phase 1/2a study BIONTECH
View entire presentation